cutaneous oncology

The many faces of melanoma
The many faces of melanomaBeginning this week, we will publish a series of case studies and quizzes on the subtypes and features of melanoma.
Case study: 20 non-melanomas and now this mysterious lesionIn this case, the clinical diagnosis can be difficult as the features of the lesion overlap in this 90-year-old patient. What is the diagnosis?
CMS grants reimbursement cods to RCMThe Centers for Medicare and Medicaid Services (CMS) has granted reimbursement codes to reflectance confocal microscopy (RCM), a noninvasive tool for identifying benign lesions, which can spare patients from needing biopsies, as well as detect malignant lesions.
Managing mycosis fungoidesAlthough there is no cure for this rare type of lymphoma, several different therapies are currently being used that can lead to long-term disease remission, significantly increasing the quality of life of patients.
Before removing lesion, investigate LMA recent study found that cosmetic treatments performed on presumed benign pigmented lesions later found to be lentigo maligna (LM) is not an uncommon occurrence, underscoring the need for individuals performing cosmetic procedures to be more vigilant in thoroughly investigating suspicious lesions.
Multispecialty collaborationCollaboration with specialists in other fields can improve outcomes for patients with skin cancer, and it can be personally and professionally rewarding for the dermatologist, according to one expert.
Checkpoint inhibitors flourishKey publications from the past year have enhanced our understanding of immunomodulatory drugs for advanced and metastatic skin cancers. Others could portend significant practice changes in areas such as sentinel lymph node (SLN) biopsy, says one dermatologist
Teledermatology viable for skin cancer diagnosisTeledermatology may play a role in skin cancer diagnsosis, an accumulating body of literature indicates, says one dermatologist.
SKs concern patientsA recent study suggests patients are bothered by seborrheic keratoses and are inclined to want the lesions removed. Dermatologist Gary Goldenberg talks about a new option in the pipeline and how best to treat these lesions with available therapies.
From mole to melanomaThere is a genetically intermediate state of melanocytic neoplasia and these findings could someday help doctors identify high-risk lesions to remove before they become malignant.